The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024.

Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-58859


"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Gene Therapy Market)."

The market is anticipated to experience certain trends like rapid adoption of personalized medicine, growing occurrence of genetic disorders, advancements in gene therapy and increasing R&D funding.

The growth of the market would be challenged by side effects of gene therapy and ethical and safety concerns and high cost of the treatment.

The fastest growing regional market is North America due to the rising incidence of cancer and other target diseases, increasing favorable reimbursement scenario in the region and improvements in healthcare infrastructure.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-58859


"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Gene Therapy Market)."

Further, the sudden outbreak of COVID-19 is causing an adverse disruption on the overall economy and society, affecting the rate of gene therapy procedures and clinical trials, which is expected to negatively impact the growth of the global gene therapy market during the forecasted period.

Scope of the report:
• The report provides a comprehensive analysis of the global gene therapy market segmented on the basis of cell type, vector type, application, end-user and region.
• The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co. (Celgene Corporation) and Gilead Sciences, Inc.) are also presented in detail.
Key Target Audience:
• Gene Therapy Manufacturers
• End Users (Hospitals, Specialty Treatment Centers & Others)
• Research Institutes and Organizations
• Government Bodies & Regulating Authorities

+ Table of Content +

1. Market Overview
1.1 Introduction
1.2 Diseases Treated by Gene Therapy
1.3 Process of Gene Therapy
1.4 Types of Gene Therapy
1.5 Application Areas for Gene Therapy
1.6 Gene Therapy Techniques
1.7 Advantages & Disadvantages of Gene Therapy
2. Impact of COVID-19
2.1 Economic Impact
2.2 Decline in Global GDP
2.3 Decline in Industrial Production
2.4 Impact on Gene Therapy
2.5 Impact on Clinical Trials of Gene Therapy